• 简

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    EDU Holdings And 2 Other ASX Penny Stocks To Consider

    Simply Wall St·07/28/2026 02:06:16
    语音播报

    Australian shares are experiencing a slight downturn, with the ASX 200 dipping as international market trends influence local trading. Despite this, the allure of penny stocks remains significant for investors interested in smaller or newer companies that offer growth potential at lower price points. These stocks, when supported by strong financials and clear business strategies, can present valuable opportunities in today's market landscape.

    Let's uncover some gems from our specialized screener.

    EDU Holdings (ASX:EDU)

    Simply Wall St Financial Health Rating: ★★★★★★

    Overview: EDU Holdings Limited, with a market cap of A$129.38 million, operates through its subsidiaries to offer tertiary education services in Australia.

    Operations: The company generates revenue through its subsidiaries, with Ikon Institute of Australia contributing A$65.95 million and Australian Learning Group Pty Limited adding A$16.46 million.

    Market Cap: A$129.38M

    EDU Holdings Limited, with a market cap of A$129.38 million, has demonstrated significant earnings growth, up 469.3% over the past year, and maintains an outstanding Return on Equity of 65.8%. The company is debt-free and offers high-quality earnings with improved profit margins from 6.2% to 18%. EDU's short-term assets cover both its short-term (A$19.4M) and long-term liabilities (A$13.2M). Trading at a substantial discount to fair value estimates and peers, EDU's revenue guidance for the second half of 2026 anticipates a notable increase by 48%, indicating strong forward momentum in its financial performance.

    ASX:EDU Revenue & Expenses Breakdown as at Jul 2026
    ASX:EDU Revenue & Expenses Breakdown as at Jul 2026

    Helloworld Travel (ASX:HLO)

    Simply Wall St Financial Health Rating: ★★★★★★

    Overview: Helloworld Travel Limited is a travel distribution company operating in Australia, New Zealand, and internationally, with a market cap of A$246.34 million.

    Operations: The company generates revenue through its Travel Operations in Australia (A$161.12 million), New Zealand (A$32.23 million), and the Rest of World (A$3.09 million).

    Market Cap: A$246.34M

    Helloworld Travel Limited, with a market cap of A$246.34 million, shows stable financial health and experienced management. The company has achieved profitability over the past five years, with earnings growing 67% annually. Its net profit margin improved to 24.7%, though recent growth slowed compared to its historical average. Helloworld's debt is well-managed, with cash exceeding total debt and liabilities covered by assets. Despite trading below estimated fair value and analyst price targets suggesting potential upside, earnings are forecasted to decline in the coming years by an average of 8.6% per year due to a large one-off gain impacting recent results.

    ASX:HLO Financial Position Analysis as at Jul 2026
    ASX:HLO Financial Position Analysis as at Jul 2026

    SomnoMed (ASX:SOM)

    Simply Wall St Financial Health Rating: ★★★★★★

    Overview: SomnoMed Limited, with a market cap of A$102.97 million, produces and sells devices for the oral treatment of sleep-related disorders across the Asia Pacific region, North America, and Europe.

    Operations: The company generates revenue of A$118.50 million from its production and sale of products designed to treat sleep disordered breathing.

    Market Cap: A$102.97M

    SomnoMed Limited, with a market cap of A$102.97 million, is navigating challenges typical for penny stocks by focusing on innovation and strategic leadership changes. The company announced the release of VirtusTM, targeting a niche market with significant demand due to its ability to address OSA and sleep bruxism. While currently unprofitable with negative return on equity (-5.11%), SomnoMed maintains a strong cash position exceeding debt and liabilities, providing over three years of runway even as free cash flow contracts slightly. Recent executive shifts aim to bolster operational efficiency amid forecasts for high single-digit revenue growth in 2027.

    ASX:SOM Revenue & Expenses Breakdown as at Jul 2026
    ASX:SOM Revenue & Expenses Breakdown as at Jul 2026

    Seize The Opportunity

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.